FolioLanternBeta
ARQTArcutis Biotherapeutics, Inc.

Sue-Jean Lin

Director at Arcutis Biotherapeutics, Inc., as of Jun 17, 2026Sold $899K of stock in the past 12 months: 13% under a disclosed plan and 87% with no plan disclosed.

Updated Oct 16, 2026 from SEC filings · covers Oct 17, 2025 to Oct 16, 2026
30K
shares sold, past 12 months
2
days with sales
$778K
largest single day, Nov 24, 2025
1
company filed for

Share of stake sold and shares held at Arcutis Biotherapeutics, Inc. are being verified and not shown yet. Why

Selling by month

Oct 2025 to Oct 2026. Each sale is counted once: under a disclosed plan, else to cover taxes, else no plan disclosed.

Disclosed planNo plan disclosedOne dollar scale for every month; the tallest bar is labeled
OctNov 2025: $778K no plan disclosed$778KNovDecJanFebMarAprMayJun 2026: $121K under a disclosed planJunJulAugSepOct

Pattern

What the filings show, past 12 months. Nothing here rates or predicts.

Roles from filings

Every company we track where this person has filed, newest filing first.

CompanyTitleFirst filingLatest filing
Arcutis Biotherapeutics, Inc. (ARQT)DirectorJun 16, 2021Jun 17, 2026

Recent filings

The last 3 days with transactions, newest first, one line per trade date. Each number links to an SEC filing.

This page shows only what this person reported on SEC ownership filings. See the methodology. Spotted something wrong? Report an error.